Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Onderzoek naar nieuw antiwormmiddel en diagnostiek in sub-Sahara Afrika
jun 2023 | Parasitaire infecties